FIELD: medicine, veterinary science.
SUBSTANCE: the present innovation deals with obtaining diagnostic preparations and could be applied for obtaining a diagnostic kit to detect antibodies to brucellosis antigen in agglutination micro-reaction (AMR), in tube agglutination reaction (AR) and in lamellar agglutination upon a slide. The innovation deals with washing microbial mass Brucella abortus 19 BA with 0.9%-sodium chloride solution, moreover, concentration of microbial mass should achieve about 20-30 bln. m.c/ml, inactivation of microbial suspension with 1%-formalin solution performed at 22° C for 2 h, washing due to centrifuging twice at 7000 rot./min for 30 min, staining microbial suspension with 0.04%-Karaci hematoxylin solution to be added at equal volume to the residue obtained after adding 0.9%-sodium chloride solution up to initial volume, then the mixture should be mixed, heated at 56° C for about 16-18 h. After staining the suspension should be centrifuged at 2000 rot./min for 15 min, then supernatant should be centrifuged at 7000 rot./min for 30 min, then the residue should be resuspended in 0.9%-sodium chloride solution and centrifuged under the same conditions three or four times, then the residue should be supplemented with 0.1%-formalin solution up to initial volume and a stabilizer at the quantity of 0.1 ml/ml of the obtained diagnostic kit. Stabilizer should be chosen out of the group: 1.5%-polyvinylpyrrolidone and 7%-saccharose solution at the ratio of 1:1 or 0.03%-carbonate buffer and 3%-saccharose solution at the ratio of 1:1. Then diagnostic kit should be lyophilized. The present innovation enables to obtain desired diagnostic kit of higher specificity, wider sphere of application (agglutination micro-reaction, tube agglutination reaction and lamellar agglutination reaction upon a slide), more prolonged validity terms and higher convenience in usage.
EFFECT: higher simplicity and availability.
2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING BRUCELLOSIS POLYSTYRENE LATEX DIAGNOSTICUM | 2022 |
|
RU2798124C1 |
METHOD OF ANTIGEN PREPARING FOR BRUCELLOSIS DIAGNOSIS | 1997 |
|
RU2133470C1 |
ANTIGEN FOR DIAGNOSIS OF GLANDES | 0 |
|
SU1837889A3 |
PSEUDOTUBERCULOUS ERYTHROCYTIC MONOCLONAL DIAGNOSTICUM | 2008 |
|
RU2377308C1 |
METHOD OF DRY FLUORESCENT SALMONELLOSIS DIAGNOSTICUM PREPARING | 2000 |
|
RU2175558C1 |
METHOD FOR PRODUCING BRUCELLOUS L-ANTIGEN | 2011 |
|
RU2486916C2 |
METHOD FOR OBTAINING ANTITULAREMIC SERUM AND METHOD FOR OBTAINING A DRY ERYTHROCYTIC TULAREMIC IMMUNOGLOBULIN TEST KIT | 2002 |
|
RU2240822C2 |
METHOD FOR PRODUCING ANTIGEN PREPARATION OF L-BRUCELLAS | 2009 |
|
RU2416429C2 |
METHOD OF PREPARATION OF ERYTHROCYTE IMMUNOGLOBULIN TULAREMIA DIAGNOSTICUM | 2020 |
|
RU2747420C1 |
METHOD FOR OBTAINING LATEX DIAGNOSTIC ANTIGENS FOR THE DETECTION OF ANTIBODIES AGAINST PATHOGENS OF BRUCELLOSIS, TULAREMIA | 2021 |
|
RU2777803C1 |
Authors
Dates
2006-02-10—Published
2004-03-12—Filed